2096:HKG
Simcere Pharmaceutical Group Ltd
11,02 HKD
arrow_upward
+1,75%(+0,19) 1D
16-окт., 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2096...
Open
10,85 HKD
High
11,29 HKD
Low
10,85 HKD
Mkt. cap
28,30 млд
Avg. vol.
4,02 млн
Volume
5,80 млн
Dividend
1,88%
Quarterly dividend
0,05 HKD
Ex-dividend date
2025-ж., 18-июн.
P/E ratio
16,54
52-wk high
14,38 HKD
52-wk low
9,07 HKD
EPS
0,67 HKD
Shares outstanding
2,57 млд
No. of employees
7 миң
Open
10,85 HKD
High
11,29 HKD
Low
10,85 HKD
Mkt. cap
28,30 млд
Avg. vol.
4,02 млн
Volume
5,80 млн
Dividend
1,88%
Quarterly dividend
0,05 HKD
Ex-dividend date
2025-ж., 18-июн.
P/E ratio
16,54
52-wk high
14,38 HKD
52-wk low
9,07 HKD
EPS
0,67 HKD
Shares outstanding
2,57 млд
No. of employees
7 миң
News stories
From web sources and news partners
Simply Wall Street
·
12 мүнөт мурун
What Viasat Doubters Got Wrong
The Fintech Times
·
52 мүнөт мурун
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
·
1 саат мурун
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees7,06 миң
Founded1995
HeadquartersNanjing, Jiangsu, Кытай
SectorPharmaceutical industry
Websitesimcere.com